Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NILOTINIB vs NIROGACESTAT HYDROBROMIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NILOTINIB vs NIROGACESTAT HYDROBROMIDE: Safety Overview

Metric NILOTINIB NIROGACESTAT HYDROBROMIDE
Total FAERS Reports 23,171 166
Deaths Reported 4,543 0
Death Rate 19.6% N/A
Hospitalizations 4,846 18
Average Patient Age 56.5 yrs 46.8 yrs
% Female Patients 47.7% 63.0%
FDA Approval Date Dec 15, 2025 Apr 4, 2024
Manufacturer Novadoz Pharmaceuticals LLC N/A
Route ORAL N/A
Marketing Status Prescription Prescription